BACKGROUND: Increased prevalence of acute pulmonary embolism in COVID-19 has been reported in few recent studies. Some works have highlighted pathological changes on lung microvasculature with local pulmonary intravascular coagulopathy that may explain pulmonary artery thrombosis found on pulmonary computed tomography (CT) angiography. The objective of our study was to describe lung perfusion disorders assessed by pulmonary dual-energy CT (DECT) angiography in severe COVID-19 patients. METHODS: This single center retrospective study included 85 consecutive patients with a reverse transcriptase-polymerase chain reaction diagnosis of SARS-CoV-2 who underwent a pulmonary DECT angiography between March 16th 2020 and April 22th 2020. Pulmonary DECT angiography was performed when the patient had severe clinical symptoms or suffered from active neoplasia or immunosuppression. Two chest radiologists performed pulmonary angiography analysis in search of pulmonary artery thrombosis and a blinded semi quantitative analysis of iodine color maps focusing on the presence of parenchymal ischemia. The lung parenchyma was divided into volumes based on HU values. DECT analysis included lung segmentation, total lungs volume and distribution of lung perfusion assessment. RESULTS: Twenty-nine patients (34%) were diagnosed with pulmonary artery thrombosis, mainly segmental (83%). Semi-quantitative analysis revealed parenchymal ischemia in 68% patients of the overall population, with no significant difference regarding absence or presence of pulmonary artery thrombosis (23 vs. 35, P=0.144). Inter-reader agreement of parenchymal ischemia between reader 1 and 2 was substantial [0.74; interquartile range (IQR): 0.59-0.89]. Volume of ischemia was significantly higher in patients with pulmonary artery thrombosis [29 (IQR, 8-100) vs. 8 (IQR, 0-45) cm3, P=0.041]. Lung parenchyma was divided between normal parenchyma (59%, of which 34% was hypoperfused), ground glass opacities (10%, of which 20% was hypoperfused) and consolidation (31%, of which 10% was hypoperfused). CONCLUSIONS: Pulmonary perfusion evaluated by iodine concentration maps shows extreme heterogeneity in COVID-19 patients and lower iodine levels in normal parenchyma. Pulmonary ischemic areas were more frequent and larger in patients with pulmonary artery thrombosis. Pulmonary DECT angiography revealed a significant number of pulmonary ischemic areas even in the absence of visible pulmonary arterial thrombosis. This may reflect microthrombosis associated with COVID-19 pneumonia. 2020 Quantitative Imaging in Medicine and Surgery. All rights reserved.
BACKGROUND: Increased prevalence of acute pulmonary embolism in COVID-19 has been reported in few recent studies. Some works have highlighted pathological changes on lung microvasculature with local pulmonary intravascular coagulopathy that may explain pulmonary artery thrombosis found on pulmonary computed tomography (CT) angiography. The objective of our study was to describe lung perfusion disorders assessed by pulmonary dual-energy CT (DECT) angiography in severe COVID-19 patients. METHODS: This single center retrospective study included 85 consecutive patients with a reverse transcriptase-polymerase chain reaction diagnosis of SARS-CoV-2 who underwent a pulmonary DECT angiography between March 16th 2020 and April 22th 2020. Pulmonary DECT angiography was performed when the patient had severe clinical symptoms or suffered from active neoplasia or immunosuppression. Two chest radiologists performed pulmonary angiography analysis in search of pulmonary artery thrombosis and a blinded semi quantitative analysis of iodine color maps focusing on the presence of parenchymal ischemia. The lung parenchyma was divided into volumes based on HU values. DECT analysis included lung segmentation, total lungs volume and distribution of lung perfusion assessment. RESULTS: Twenty-nine patients (34%) were diagnosed with pulmonary artery thrombosis, mainly segmental (83%). Semi-quantitative analysis revealed parenchymal ischemia in 68% patients of the overall population, with no significant difference regarding absence or presence of pulmonary artery thrombosis (23 vs. 35, P=0.144). Inter-reader agreement of parenchymal ischemia between reader 1 and 2 was substantial [0.74; interquartile range (IQR): 0.59-0.89]. Volume of ischemia was significantly higher in patients with pulmonary artery thrombosis [29 (IQR, 8-100) vs. 8 (IQR, 0-45) cm3, P=0.041]. Lung parenchyma was divided between normal parenchyma (59%, of which 34% was hypoperfused), ground glass opacities (10%, of which 20% was hypoperfused) and consolidation (31%, of which 10% was hypoperfused). CONCLUSIONS: Pulmonary perfusion evaluated by iodine concentration maps shows extreme heterogeneity in COVID-19 patients and lower iodine levels in normal parenchyma. Pulmonary ischemic areas were more frequent and larger in patients with pulmonary artery thrombosis. Pulmonary DECT angiography revealed a significant number of pulmonary ischemic areas even in the absence of visible pulmonary arterial thrombosis. This may reflect microthrombosis associated with COVID-19 pneumonia. 2020 Quantitative Imaging in Medicine and Surgery. All rights reserved.
Authors: Pietro Spagnolo; Andrea Cozzi; Riccardo Alessandro Foà; Angelo Spinazzola; Lorenzo Monfardini; Claudio Bnà; Marco Alì; Simone Schiaffino; Francesco Sardanelli Journal: Quant Imaging Med Surg Date: 2020-06
Authors: Fabio Ciceri; Luigi Beretta; Anna Mara Scandroglio; Sergio Colombo; Giovanni Landoni; Annalisa Ruggeri; Jacopo Peccatori; Armando D'Angelo; Francesco De Cobelli; Patrizia Rovere-Querini; Moreno Tresoldi; Lorenzo Dagna; Alberto Zangrillo Journal: Crit Care Resusc Date: 2020-04-15 Impact factor: 2.159
Authors: Saskia Middeldorp; Michiel Coppens; Thijs F van Haaps; Merijn Foppen; Alexander P Vlaar; Marcella C A Müller; Catherine C S Bouman; Ludo F M Beenen; Ruud S Kootte; Jarom Heijmans; Loek P Smits; Peter I Bonta; Nick van Es Journal: J Thromb Haemost Date: 2020-07-27 Impact factor: 5.824
Authors: Scott Simpson; Fernando U Kay; Suhny Abbara; Sanjeev Bhalla; Jonathan H Chung; Michael Chung; Travis S Henry; Jeffrey P Kanne; Seth Kligerman; Jane P Ko; Harold Litt Journal: J Thorac Imaging Date: 2020-07 Impact factor: 3.000
Authors: Helen Fogarty; Liam Townsend; Cliona Ni Cheallaigh; Colm Bergin; Ignacio Martin-Loeches; Paul Browne; Christopher L Bacon; Richard Gaule; Alexander Gillett; Mary Byrne; Kevin Ryan; Niamh O'Connell; Jamie M O'Sullivan; Niall Conlon; James S O'Donnell Journal: Br J Haematol Date: 2020-05-17 Impact factor: 8.615
Authors: Ioannis Vlahos; Megan C Jacobsen; Myrna C Godoy; Konstantinos Stefanidis; Rick R Layman Journal: Br J Radiol Date: 2021-09-24 Impact factor: 3.039
Authors: Bence Farkas; Zita Képes; Sándor Kristóf Barna; Viktória Szugyiczki; Magdolna Bakos; Attila Forgács; Ildikó Garai Journal: Ann Nucl Med Date: 2022-06-28 Impact factor: 2.258
Authors: Florian Poschenrieder; Stefanie Meiler; Matthias Lubnow; Florian Zeman; Janine Rennert; Gregor Scharf; Jan Schaible; Christian Stroszczynski; Michael Pfeifer; Okka W Hamer Journal: PLoS One Date: 2021-06-08 Impact factor: 3.240